Literature DB >> 27424478

Risk factors for and impact of respiratory failure on mortality in the early phase of acute pancreatitis.

Tilde Dombernowsky1, Marlene Østermark Kristensen1, Sisse Rysgaard1, Lise Lotte Gluud1, Srdan Novovic2.   

Abstract

BACKGROUND: The incidence of respiratory failure and other respiratory complications in the early phase of acute pancreatitis (AP) is not well investigated.
OBJECTIVE: To evaluate the incidence and risk factors of respiratory failure, and its impact on mortality in the early phase AP.
METHODS: Retrospective cohort study including 359 patients admitted with acute pancreatitis. Information was gathered from electronic patient records. We defined respiratory failure based on the modified Marshall scoring system in the revised Atlanta criteria. Predictors of respiratory failure were evaluated in univariable and multivariable logistic regression analysis.
RESULTS: The cohort included 188 women and 171 men with a mean age of 56.1 years. Respiratory complications including pleural effusion, pneumonia and atelectasis were registered in 80 patients (22%), 100 (29%) needed oxygen therapy, 27 (8%) continuous positive airway pressure, and six (2%) mechanical ventilation. Thirty-two patients (9%) were treated with bronchodilators and 12 (3%) with steroids. Thirty-one patients (9%) fulfilled the diagnostic criteria for respiratory failure. Five of these patients (16%) did not have effusion, atelectasis or pneumonia. Predictors of respiratory failure in multivariable analysis were age (OR 1.04; CI 95% (1.03-1.07)) and smoking (OR 2.67; CI 95% (1.21-5.86)). Thirteen patients died in hospital. The Kaplan-Meier curves and log-rank tests showed that patients with respiratory failure had increased in-hospital mortality as did patients with cardiovascular and renal failure (P < 0.01 for all analyses).
CONCLUSIONS: Respiratory complications are frequent in the early phase of AP. Respiratory, cardiovascular and renal failure is associated with a poor outcome. The fact that patients without effusion, atelectasis, or pneumonia may develop respiratory failure, suggests that acute lung injury, possibly associated with systemic inflammation, may be important.
Copyright © 2016 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Mortality; Organ failure; Respiratory complications; Respiratory failure

Mesh:

Year:  2016        PMID: 27424478     DOI: 10.1016/j.pan.2016.06.664

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  13 in total

Review 1.  Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.

Authors:  Lise L Gluud; Rebecca Jeyaraj; Marsha Y Morgan
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

2.  Effects of Tec Tyrosine Kinase Inhibition on the Inflammatory Response of Severe Acute Pancreatitis-Associated Acute Lung Injury in Mice.

Authors:  Yiteng Meng; Shuo Sha; Jing Yang; Hongbo Ren
Journal:  Dig Dis Sci       Date:  2019-02-14       Impact factor: 3.199

3.  Factors predicting the severity of acute pancreatitis in elderly patients.

Authors:  Fang He; Hong-Ming Zhu; Bang-Yi Li; Xiao-Cui Li; Shuang Yang; Zhe Wang; Mei Zhang
Journal:  Aging Clin Exp Res       Date:  2020-03-17       Impact factor: 3.636

4.  Epidural analgesia in critically ill patients with acute pancreatitis: the multicentre randomised controlled EPIPAN study protocol.

Authors:  Stéphanie Bulyez; Bruno Pereira; Elodie Caumon; Etienne Imhoff; Laurence Roszyk; Lise Bernard; Leo Bühler; Claudia Heidegger; Samir Jaber; Jean-Yves Lefrant; Russell Chabanne; Pierre-Marie Bertrand; Pierre-François Laterre; Philippe Guerci; Pierre-Eric Danin; Etienne Escudier; Achille Sossou; Dominique Morand; Vincent Sapin; Jean-Michel Constantin; Matthieu Jabaudon
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

5.  Pulmonary complications in dogs with acute presentation of pancreatitis.

Authors:  Eleonora Gori; Alessio Pierini; Gianila Ceccherini; Simonetta Citi; Tommaso Mannucci; Ilaria Lippi; Veronica Marchetti
Journal:  BMC Vet Res       Date:  2020-06-22       Impact factor: 2.741

6.  Rationally designed pure-inorganic upconversion nanoprobes for ultra-highly selective hydrogen sulfide imaging and elimination in vivo.

Authors:  Yuxin Liu; Qi Jia; Xuejiao Zhai; Fang Mao; Anqi Jiang; Jing Zhou
Journal:  Chem Sci       Date:  2018-11-12       Impact factor: 9.825

7.  Effects of Bacterial Translocation and Autophagy on Acute Lung Injury Induced by Severe Acute Pancreatitis.

Authors:  Hanlin Wang; Chang Li; Yingjian Jiang; Hongbo Li; Dianliang Zhang
Journal:  Gastroenterol Res Pract       Date:  2020-02-13       Impact factor: 2.260

8.  Chest computed tomography semi-quantitative pleural effusion and pulmonary consolidation are early predictors of acute pancreatitis severity.

Authors:  Rong Peng; Ling Zhang; Ze-Ming Zhang; Zhi-Qing Wang; Guang-Yu Liu; Xiao-Ming Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-02

9.  Lipoxin A4 Ameliorates Acute Pancreatitis-Associated Acute Lung Injury through the Antioxidative and Anti-Inflammatory Effects of the Nrf2 Pathway.

Authors:  Wen Ye; Chenlei Zheng; Dinglai Yu; Fan Zhang; Reguang Pan; Xiaofeng Ni; Zhehao Shi; Zhongjing Zhang; Yukai Xiang; Hongwei Sun; Keqing Shi; Bicheng Chen; Qiyu Zhang; Mengtao Zhou
Journal:  Oxid Med Cell Longev       Date:  2019-11-06       Impact factor: 6.543

10.  Correlation Between Severity of Illness and Levels of Free Triiodothyronine, Interleukin-6, and Interleukin-10 in Patients with Acute Pancreatitis.

Authors:  Fei Tian; Fei Tian; Fei Tian; Tianjiao Lin; Tianjiao Lin; Tianjiao Lin; Qingyun Zhu; Qingyun Zhu; Qingyun Zhu; Youdong Wan; Youdong Wan; Youdong Wan; Ziqian Wu; Ziqian Wu; Ziqian Wu; Shaoyan Lv; Shaoyan Lv; Shaoyan Lv; Jingyu Song; Jingyu Song; Jingyu Song; Ruomeng Li; Ruomeng Li; Ruomeng Li; Yunyun Wang; Yunyun Wang; Yunyun Wang; Yushi Zhang; Yushi Zhang; Yushi Zhang; Xu Yan; Xu Yan; Xu Yan; Xinting Pan; Xinting Pan; Xinting Pan
Journal:  Med Sci Monit       Date:  2022-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.